These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15803361)

  • 1. Genetic polymorphisms of TGF-beta1 & TNF-beta and breast cancer risk.
    Lee KM; Park SK; Hamajima N; Tajima K; Yoo KY; Shin A; Noh DY; Ahn SH; Hirvonen A; Kang D
    Breast Cancer Res Treat; 2005 Mar; 90(2):149-55. PubMed ID: 15803361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of GSTM1, GSTT1, and COMT genotypes in individual breast cancer risk.
    Park SK; Yim DS; Yoon KS; Choi IM; Choi JY; Yoo KY; Noh DY; Choe KJ; Ahn SH; Hirvonen A; Kang D
    Breast Cancer Res Treat; 2004 Nov; 88(1):55-62. PubMed ID: 15538046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic polymorphisms of the transforming growth factor-beta1 gene and breast cancer risk: a possible dual role at different cancer stages.
    Shin A; Shu XO; Cai Q; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1567-70. PubMed ID: 15941974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione S-transferase M1, M3, P1, and T1 genetic polymorphisms and susceptibility to breast cancer.
    Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Vainio H; Uusitupa M; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):229-36. PubMed ID: 11303592
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
    Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms of NOS3 are associated with the risk of invasive breast cancer with lymph node involvement.
    Lee KM; Choi JY; Lee JE; Noh DY; Ahn SH; Han W; Yoo KY; Hayes RB; Kang D
    Breast Cancer Res Treat; 2007 Dec; 106(3):433-8. PubMed ID: 17262178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined genetic assessment of transforming growth factor-beta signaling pathway variants may predict breast cancer risk.
    Kaklamani VG; Baddi L; Liu J; Rosman D; Phukan S; Bradley C; Hegarty C; McDaniel B; Rademaker A; Oddoux C; Ostrer H; Michel LS; Huang H; Chen Y; Ahsan H; Offit K; Pasche B
    Cancer Res; 2005 Apr; 65(8):3454-61. PubMed ID: 15833881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study.
    Metsola K; Kataja V; Sillanpää P; Siivola P; Heikinheimo L; Eskelinen M; Kosma VM; Uusitupa M; Hirvonen A
    Breast Cancer Res; 2005; 7(6):R987-97. PubMed ID: 16280050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T29C polymorphism in the transforming growth factor beta1 gene and postmenopausal breast cancer risk: the Multiethnic Cohort Study.
    Le Marchand L; Haiman CA; van den Berg D; Wilkens LR; Kolonel LN; Henderson BE
    Cancer Epidemiol Biomarkers Prev; 2004 Mar; 13(3):412-5. PubMed ID: 15006917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms of ataxia telangiectasia mutated and breast cancer risk.
    Lee KM; Choi JY; Park SK; Chung HW; Ahn B; Yoo KY; Han W; Noh DY; Ahn SH; Kim H; Wei Q; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):821-5. PubMed ID: 15824150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic polymorphisms in the IGFBP3 gene: association with breast cancer risk and blood IGFBP-3 protein levels among Chinese women.
    Ren Z; Cai Q; Shu XO; Cai H; Li C; Yu H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1290-5. PubMed ID: 15298948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polymorphisms in TGF-beta1 gene and the risk of lung cancer.
    Kang HG; Chae MH; Park JM; Kim EJ; Park JH; Kam S; Cha SI; Kim CH; Park RW; Park SH; Kim YL; Kim IS; Jung TH; Park JY
    Lung Cancer; 2006 Apr; 52(1):1-7. PubMed ID: 16499994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.
    Chacko P; Rajan B; Joseph T; Mathew BS; Pillai MR
    Breast Cancer Res Treat; 2005 Jan; 89(1):15-21. PubMed ID: 15666192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
    Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Kang D; Vainio H; Uusitupa M; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):635-40. PubMed ID: 11401913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of breast cancer risk with a common functional polymorphism (Asp327Asn) in the sex hormone-binding globulin gene.
    Cui Y; Shu XO; Cai Q; Jin F; Cheng JR; Cai H; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1096-101. PubMed ID: 15894658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect modification by catalase genotype suggests a role for oxidative stress in the association of hormone replacement therapy with postmenopausal breast cancer risk.
    Quick SK; Shields PG; Nie J; Platek ME; McCann SE; Hutson AD; Trevisan M; Vito D; Modali R; Lehman TA; Seddon M; Edge SB; Marian C; Muti P; Freudenheim JL
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1082-7. PubMed ID: 18483329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.